Atlas Trials

Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

Clinical trial NCT03147677 · COMPLETED

Trial details

NCT number
NCT03147677
Sponsor
The Third Xiangya Hospital of Central South University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetic Nephropathy
Start date
2016-07-28
Primary completion
2018-07-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.